drugset

drugset / Trial / NCT02489292

Study to Evaluate the Efficacy of HepaStem in Urea Cycle Disorders Paediatric Patients (HEP002)

NCT02489292 ↗

Phase 2 Completed 5 enrolled Cellaion SA

NaSingle-groupOpen-labelTreatment

Summary

The aim of the study is to assess the efficacy of HepaStem treatment in paediatric patients suffering from urea cycle disorders.

Timeline

Start: 2014-10
Primary completion: 2017-03
Completion: 2017-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HepaStem	Cell therapy	5e+07 cells/kg	Other

Indications